These studies indicate that some of the biomarkers elevated in CP are also elevated in patients with AP (e.g., IL-6, IL-2, MCP-1) and in patients with RAP (e.g., MCP-1, 4-HNE, MDA). Here, CCL2 is linked to alkaline phosphatase measurement.